IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
64 hedge funds and large institutions have $595M invested in IVERIC bio, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.
6,852% more call options, than puts
Call options by funds: $4.03M | Put options by funds: $58K
1,727% more capital invested
Capital invested by funds: $32.6M → $595M (+$562M)
917% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 6
611% more funds holding
Funds holding: 9 → 64 (+55)
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$205M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$55.7M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$47.5M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$24.6M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$19.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$7.84M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.78M |
| 3 |
VM
VHCP Management
New York
|
-$1.56M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.16M |
| 5 |
ICAP
Independence Capital Asset Partners
Denver,
Colorado
|
-$1.13M |
ISEE Hedge Fund Activity: Q4 2013 in Review
64 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2013, worth a combined $595M — up 1,727% from $32.6M a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new ISEE positions and 6 closed out — a net gain of 55 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $205M. The largest seller was Columbia Wanger Asset Management, exiting entirely with an estimated $7.84M sold.
- 64 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2013, up from 9 in Q3 2013.
- Funds reported $595M of IVERIC bio, Inc. Common Stock stock for Q4 2013, up 1,727% quarter-over-quarter.
- 61 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2013 and 6 closed out, a net change of +55 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q4 2013 was Novo Holdings A/S, an estimated $205M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q4 2013 was Columbia Wanger Asset Management, an estimated $7.84M sold.
Based on aggregated 13F filings for Q4 2013.